Compound Information | SONAR Target prediction |
Name: | Propofol |
Unique Identifier: | Prest1289 |
MolClass: | Checkout models in ver1.5 and ver1.0 |
Molecular Formula: | C12H18O |
Molecular Weight: | 160.128 g/mol |
X log p: | 6.474 (online calculus) |
Lipinksi Failures | 1 |
TPSA | 0 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptors Count: | 1 |
Rotatable Bond Count: | 2 |
Canonical Smiles: | CC(C)c1cccc(C(C)C)c1O |
Generic_name: | Propofol |
Chemical_iupac_name: | 2,6-dipropan-2-ylphenol |
Drug_type: | Approved Drug |
Pharmgkb_id: | PA451141 |
Kegg_compound_id: | C07523 |
Drugbank_id: | APRD01201 |
Melting_point: | 18 oC |
H2o_solubility: | 124 mg/L |
Logp: | 3.842 |
Isoelectric_point: | 11.1 |
Cas_registry_number: | 2078-54-8 |
Mass_spectrum: | http://webbook.nist.gov/cgi/cbook.cgi?Spec=C2078548&Index=0&Type=Mass&Large=on |
Drug_category: | Anesthetics, Intravenous; Anticonvulsants; Antiemetics; Free Radical Scavengers; Hypnotics and Sedatives; ATC:N01AX10 |
Indication: | Used for both induction and/or maintenance of anesthesia. |
Pharmacology: | Propofol a sedative-hypnotic agent for use in the induction and maintenance of anesthesia or sedation. Intravenous injection of a therapeutic dose of propofol produces hypnosis rapidly with minimal excitation, usually within 40 seconds from the start of an injection (the time for one arm-brain circulation). |
Mechanism_of_action: | The action of propofol involves a positive modulation of the inhibitory function of the neurotransmitter gama-aminobutyric acid(GABA) through GABA-A receptors. |
Organisms_affected: | Humans and other mammals |